首页> 美国卫生研究院文献>Gastroenterology Research and Practice >Transanal Irrigation for Refractory Chronic Idiopathic Constipation: Patients Perceive a Safe and Effective Therapy
【2h】

Transanal Irrigation for Refractory Chronic Idiopathic Constipation: Patients Perceive a Safe and Effective Therapy

机译:经肛门冲洗治疗难治性慢性特发性便秘:患者认为一种安全有效的疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. Transanal irrigation (TAI) can successfully treat neurogenic bowel dysfunction (NBD), but patient perception of its use in chronic idiopathic constipation (CIC) is unknown. Objective. To evaluate patient perceptions of the efficacy and safety of TAI for CIC and whether there are predictive factors of perceived treatment response. Methods. Prospective data collection of baseline physiology and symptom severity; retrospective evaluation of efficacy and safety perceptions using a snapshot survey. All patients fulfilling the Rome III criteria for functional constipation with chronic idiopathic aetiology were included. The main outcome measure was the duration of patients' usage of TAI. Results. 102 patients reported 21,476 irrigations over 119 patient years, with a mean duration of therapy use of 60.5 weeks [SD 73.2 : SE 7.3]. Overall symptom improvement included general well-being (65%), rectal clearance (63%), bloating (49%), abdominal pain (48%), and bowel frequency (42%). 68 patients (67%) were “moderately better” or “very much better” on a satisfaction question. Reported complications were minor. No correlation was demonstrated between duration of therapy use and baseline measures. Conclusion. A significant proportion of CIC sufferers use TAI as a long-term or bridging therapy and perceive it as safe. This therapy demands a prospective investigation of efficacy and safety.
机译:背景。经肛门冲洗(TAI)可以成功治疗神经源性肠功能障碍(NBD),但尚不清楚患者对其在慢性特发性便秘(CIC)中使用的认识。目的。评估患者对CIC的TAI疗效和安全性的认知以及是否存在感知到的治疗反应的预测因素。方法。前瞻性收集基线生理和症状严重程度的数据;使用快照调查对疗效和安全性认识进行回顾性评估。纳入所有符合罗马三期功能性便秘标准并伴有慢性特发性病因的患者。主要结局指标是患者使用TAI的持续时间。结果。 102名患者报告了119个患者年中进行了21476次冲洗,平均治疗时间为60.5周[SD 73.2:SE 7.3]。总体症状改善包括总体健康(65%),直肠间隙(63%),腹胀(49%),腹痛(48%)和排便频率(42%)。 68名患者(67%)在满意度问题上为“中度好转”或“非常好转”。报告的并发症较小。在治疗的持续时间和基线测量之间未显示出相关性。结论。很大一部分CIC患者将TAI用作长期或过渡疗法,并认为它是安全的。这种疗法需要对疗效和安全性进行前瞻性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号